Xarelto is not currently available as a generic medication in the United States. The drug's active ingredient is rivaroxaban [1].
When Could a Generic Version of Xarelto Become Available?
The availability of a generic version of Xarelto depends on patent expirations and any subsequent legal challenges. Information on specific patent dates and potential generic entry is available through resources like DrugPatentWatch.com [2]. As of now, the exact timeline for generic Xarelto availability is not publicly disclosed or widely confirmed.
What is Xarelto Used For?
Xarelto is a prescription medication used to reduce the risk of stroke and blood clots in people with atrial fibrillation (AFib) not caused by a heart valve problem [1]. It is also used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE), and to lower the risk of DVT and PE in certain patients who have just had hip or knee replacement surgery [1].
How Does Xarelto Work?
Xarelto is a direct oral anticoagulant. It works by inhibiting factor Xa, a key component in the blood clotting cascade, thereby preventing the formation of blood clots [1].
Who Manufactures Xarelto?
Xarelto is manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, and Bayer [1].
Are There Alternatives to Xarelto?
Other anticoagulant medications are available, including warfarin, which has been used for many years. Newer direct oral anticoagulants (DOACs) such as apixaban (Eliquis), dabigatran (Pradaxa), and edoxaban (Savaysa) are also alternatives to Xarelto [3]. The choice of medication depends on individual patient needs, medical history, and physician recommendation.
What Are the Risks Associated with Xarelto?
The primary risk associated with Xarelto, like other anticoagulants, is bleeding. This can range from minor bruising to severe, life-threatening hemorrhage [1]. Patients taking Xarelto should be aware of signs of bleeding and report them to their doctor immediately.